Published in Am J Pathol on October 01, 1982
Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis. J Clin Invest (1984) 2.03
Sequential pathology of the gills of Coho salmon with a combined diatom and microsporidian gill infection. Can Vet J (1989) 1.38
Kinetics of the bronchoalveolar leucocyte response in rats during exposure to equal airborne mass concentrations of quartz, chrysotile asbestos, or titanium dioxide. Thorax (1988) 1.32
Role of polymorphonuclear leukocytes in silica-induced pulmonary fibrosis. Am J Pathol (1984) 1.14
The ability of inflammatory bronchoalveolar leucocyte populations elicited with microbes or mineral dust to injure alveolar epithelial cells and degrade extracellular matrix in vitro. Br J Exp Pathol (1988) 1.11
Secretion of monocyte chemotactic activity by alveolar macrophages. Am J Pathol (1989) 0.99
Expression of inducible nitric oxide synthase and its involvement in pulmonary granulomatous inflammation in rats. Am J Pathol (1996) 0.96
Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphoma. Br J Cancer (1998) 0.86
Peritoneal lavage fluids stimulate NIH3T3 fibroblast proliferation and contain increased tumour necrosis factor and IL-6 in experimental silica-induced rat peritonitis. Clin Exp Immunol (1995) 0.78
Decreased sialidase activity in alveolar macrophages of guinea pigs exposed to coal mine dust. Environ Health Perspect (1992) 0.75
The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med (1962) 23.03
Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest (1977) 4.21
Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung. N Engl J Med (1980) 2.07
Complement fragments, alveolar macrophages, and alveolitis. Am J Pathol (1979) 1.69
Lung and dermal vascular injury produced by preformed immune complexes. Am Rev Respir Dis (1978) 1.64
High prevalence of antinuclear antibodies in sandblasters' silicosis. Am Rev Respir Dis (1976) 1.51
Chemotactic activity of guinea pig alveolar macrophages. Am Rev Respir Dis (1978) 1.32
Silica stimulation of chemotactic factor release by guinea pig alveolar macrophages. J Reticuloendothel Soc (1981) 1.27
Experimental silicosis: morphologic and biochemical abnormalities produced by intratracheal instillation of quartz into guinea pig lungs. Am J Pathol (1980) 1.25
Effects of C5a on baboon alveolar macrophage migration. Am Rev Respir Dis (1981) 0.87
Immunologic abnormalities in sarcoidosis. Ann Intern Med (1980) 2.66
Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial lung disease. Ann Intern Med (1985) 2.42
Clinical role of bronchoalveolar lavage in adults with pulmonary disease. Am Rev Respir Dis (1990) 2.02
Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. J Clin Invest (1988) 1.93
Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease. Ann Intern Med (1988) 1.77
Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients. Hum Immunol (1985) 1.65
A potassium ionophore (valinomycin) inhibits lymphocyte proliferation by its effects on the cell membrane. Proc Natl Acad Sci U S A (1976) 1.61
Transmembrane electrical and pH gradients across human erythrocytes and human peripheral lymphocytes. J Cell Physiol (1979) 1.57
A phorbol ester (TPA) can replace macrophages in human lymphocyte cultures stimulated with a mitogen but not with an antigen. J Immunol (1982) 1.52
Surface receptors in the immune response. N Engl J Med (1975) 1.51
Human alveolar macrophage inhibition of lung fibroblast growth. A prostaglandin-dependent process. Am Rev Respir Dis (1985) 1.45
Immunocompetent cells from the lower respiratory tract of normal human lungs. J Clin Invest (1975) 1.44
Lymphocyte studies in asymptomatic cigarette smokers. A comparison between lung and peripheral blood. Am Rev Respir Dis (1977) 1.41
Proteins of the respiratory tract after heart-lung transplantation. Transplantation (1989) 1.40
Lung transplantation for end-stage pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (1999) 1.40
Differential interleukin 1 elaboration by unfractionated and density fractionated human alveolar macrophages and blood monocytes: relationship to cell maturity. J Immunol (1985) 1.32
Chemotactic activity of guinea pig alveolar macrophages. Am Rev Respir Dis (1978) 1.32
Immune complexes in sarcoidosis: a correlation with activity and duration of disease. Chest (1978) 1.28
Silica stimulation of chemotactic factor release by guinea pig alveolar macrophages. J Reticuloendothel Soc (1981) 1.27
Experimental silicosis: morphologic and biochemical abnormalities produced by intratracheal instillation of quartz into guinea pig lungs. Am J Pathol (1980) 1.25
Heart-lung transplantation: lessons learned and future hopes. Ann Thorac Surg (1987) 1.23
Nutritional status and lung function in patients with emphysema and chronic bronchitis. Chest (1983) 1.23
The regulation of lung fibroblast proliferation by alveolar macrophages in experimental silicosis. Am Rev Respir Dis (1984) 1.19
Identification, cellular localization, isolation, and characterization of human Clara cell-specific 10 KD protein. J Histochem Cytochem (1988) 1.17
The alveolar macrophage: its capacity to act as an accessory cell in mitogen-stimulated proliferation of guinea pig lymphocytes. Cell Immunol (1978) 1.17
Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation (1991) 1.13
Evidence for an interleukin-independent pathway for human lymphocyte activation. Proc Natl Acad Sci U S A (1983) 1.10
Pulmonary fibrosis: bronchoalveolar cell types and impaired function of alveolar macrophages in experimental silicosis. Environ Res (1982) 1.09
Immune complex injury of the lung. Symposium held at the 74th annual meeting of the American Thoracic Society, Las Vegas, Nevada, May 1979. Am Rev Respir Dis (1981) 1.08
Quantitative relationships between single-cell and cell-population model parameters for chemosensory migration responses of alveolar macrophages to C5a. Cell Motil Cytoskeleton (1990) 1.07
Alveolar macrophages, blood monocytes, and density-fractionated alveolar macrophages differ in their ability to promote lymphocyte proliferation to mitogen and antigen. Am Rev Respir Dis (1987) 1.07
Bronchoalveolar lavage in a patient with chronic berylliosis: evidence for hypersensitivity pneumonitis. Ann Intern Med (1982) 1.07
Neutrophil alveolitis following endotoxemia. Enhancement by previous exposure to hyperoxia. Am Rev Respir Dis (1984) 1.06
Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest (1998) 1.05
Secretion of chemotaxins by guinea pig lung macrophages. I. The spectrum of inflammatory cell responses. Exp Lung Res (1980) 1.03
Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients. Am Rev Respir Dis (1992) 1.01
Immunologically mediated disease of the airways after pulmonary transplantation. Ann Surg (1988) 1.00
Bronchial cartilage alterations in lung transplantation. Chest (1990) 0.99
Cytomegalovirus infection and survival in lung transplant recipients. J Heart Lung Transplant (1992) 0.99
Bronchoalveolar cell populations in acute sarcoidosis. Observations in smoking and nonsmoking patients. J Lab Clin Med (1979) 0.99
Characterization of immunocompetent cells recovered from the respiratory tract and tracheobronchial lymph node of normal guinea pigs. Am Rev Respir Dis (1976) 0.99
Lymphocyte subpopulations in sarcoidosis: correlation with disease aetivity and duration. Ann Intern Med (1976) 0.98
Spontaneous production of interleukin-1 by human alveolar macrophages. Clin Immunol Immunopathol (1983) 0.98
Lymphocyte phenotypes in bronchoalveolar lavage and lung tissue in sarcoidosis and idiopathic pulmonary fibrosis. Am Rev Respir Dis (1986) 0.98
Pulmonary capillary hemangiomatosis. A report of three cases and a review of the literature. Am Rev Respir Dis (1989) 0.98
Recurrence of sarcoidosis in pulmonary allograft recipients. Am Rev Respir Dis (1993) 0.98
Differentiation and activation phenotypes of lung T lymphocytes differ from those of circulating T lymphocytes. J Clin Invest (1985) 0.97
Kinetics of human lymphocyte proliferation: proportion of cells responsive to phytohemagglutinin and correlation with E rosette formation. J Reticuloendothel Soc (1975) 0.97
Role of alveolar macrophages in endotoxin-induced neutrophilic alveolitis in rats. Tissue Cell (1985) 0.96
Acute rejection of lung allografts with various immunosuppressive protocols. Ann Thorac Surg (1992) 0.96
Chronic beryllium disease in a precious metal refinery. Clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume. Am Rev Respir Dis (1987) 0.95
Lymphocyte enumeration: a comparison between a modified avidin-biotin-immunoperoxidase system and flow cytometry. J Histochem Cytochem (1984) 0.95
Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis. J Lab Clin Med (1986) 0.94
Separation of bronchoalveolar cells from the guinea pig on continuous gradients of Percoll: functional properties of fractionated lung macrophages. J Reticuloendothel Soc (1983) 0.94
The bronchoalveolar lymphocyte. Studies on the life history and lymphocyte traffic from blood to the lung. Cell Immunol (1977) 0.94
The role of the accessory cell in mitogen-stimulated human T cell gene expression. J Immunol (1986) 0.94
Aerosolized cyclosporine in lung recipients with refractory chronic rejection. Am J Respir Crit Care Med (1996) 0.93
The role of calcium in the initiation of superoxide release from alveolar macrophages. J Cell Physiol (1982) 0.92
Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans. Eur Respir J (2004) 0.92
Patient response to transtracheal oxygen delivery. Am Rev Respir Dis (1987) 0.91
Augmentation of rat alveolar macrophage migration by surfactant protein. Am Rev Respir Dis (1987) 0.91
Role of microtubules in random cell migration: stabilization of cell polarity. Cell Motil Cytoskeleton (1994) 0.90
Preservation of post-transplant lung function with aerosol cyclosporin. Eur Respir J (2004) 0.90
Dose-related reversal of acute lung rejection by aerosolized cyclosporine. Am J Respir Crit Care Med (1997) 0.89
Pulmonary sarcoidosis: correlation of serum angiotensin-converting enzyme with blood and bronchoalveolar lymphocytes. Am Rev Respir Dis (1982) 0.89
Spirometry values in stable lung transplant recipients. Am J Respir Crit Care Med (1997) 0.89
Lymphocytes of bronchoalveolar lavages from heart-lung transplant recipients. J Heart Transplant (1987) 0.89
Antibodies to T cells in sarcoidosis. Ann N Y Acad Sci (1976) 0.89
Blunted respiratory drive in congenital myopathy. Am J Med (1977) 0.88
The importance of bronchoscopy with transbronchial biopsy and bronchoalveolar lavage in the management of lung transplant recipients. Am J Respir Crit Care Med (1995) 0.87
Separation of bronchoalveolar cells from the guinea pig on continuous density gradients of Percoll: morphology and cytochemical properties of fractionated lung macrophages. J Reticuloendothel Soc (1983) 0.87
Rapid detection of cytomegalovirus pneumonia from lung lavage cells. Am Rev Respir Dis (1988) 0.87
Pulmonary arteriosclerosis in long-term human heart-lung transplant recipients. Transplantation (1989) 0.87
Inhibition of human lung fibroblast growth by mononuclear cells. Am Rev Respir Dis (1982) 0.86
Lymphocyte response to phytohemagglutinin: intracellular volume and intracellular [K+]. J Cell Physiol (1979) 0.86
Proliferative responses of bronchoalveolar lavage lymphocytes from heart-lung transplant patients. Transplantation (1990) 0.86
Neutrophils, unopposed neutrophil elastase, and alpha1-antiprotease defenses following human lung transplantation. Am J Respir Crit Care Med (2001) 0.85
Allograft colonization and infections with pseudomonas in cystic fibrosis lung transplant recipients. Chest (1998) 0.85
Interleukin-1-beta gene expression in human monocytes and alveolar macrophages from normal subjects and patients with sarcoidosis. Am Rev Respir Dis (1988) 0.85
Enhanced secretion of immune-modulating cytokines by human lung fibroblasts during in vitro infection with Mycoplasma fermentans. Am J Respir Cell Mol Biol (1993) 0.85
Case report: fluconazole therapy in histoplasma mediastinal granuloma. Am J Med Sci (1994) 0.85
Balloon dilation and endobronchial stent placement for bronchial strictures after lung transplantation. J Vasc Interv Radiol (2000) 0.85
Sequential proliferation induced in human peripheral blood lymphocytes by mitogen. II. Suppression by PHA-activated cells. J Immunol (1977) 0.84
Accessory cells provide more than one signal for lectin mitogen-stimulated proliferation of human lymphocytes. J Leukoc Biol (1985) 0.84